Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1)

Molecular Endocrinology

Volumn 13, Issue 1, 1999, Pages 24-37

  Florio, Tullio ^b   Yao, Hong ^a   Carey, Kendall D ^a   Dillon, Tara J ^a   Stork, Philip J S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; ENZYME ACTIVATION; GROWTH REGULATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; NONHUMAN; PRIORITY JOURNAL; SOMATOSTATIN RELEASE;

ANIMALIA;

EID: 0002709117     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.1.0224     Document Type: Article

References (90)

1. Florio T, Rim C, Hershberger RE, Loda M, Stork PJS 1994 The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol 8:1289-1297
2. Reubi JC, Maurer R, von Werder K, Torhorst J, Klijn JGM, Lamberts SWJ 1987 Somatostatin receptors in human endocrine tumors. Cancer Res 47:551-558
3. Bell GI, Reisine T 1993 Molecular biology of somatostatin receptors. Trends Neurosci 16:34-38
4. Dy DY, Whitehead RH, Morris DL 1992 SMS 201.995 inhibits in vitro and in vivo growth of human colon cancer. Cancer Res 52:917-923
5. Prévost G, Foehrlé E, Thomas F, Pihan I, Veber N, Starzec A, Israël L 1991 Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM23014. Endocrinology 29:323-329
6. Qin Y, Schally AV, Willems G 1991 Somatostatin analogues RC-160 inhibits the growth of transplanted colon cancer in rats. Int J Cancer 47:765-770
7. Florio T, Scorziello A, Fattore M, D'Alto V, Salzano S, Rossi G, Berlingieri MT, Fusco A, Schettini G 1996 Somatostatin inhibits PC C13 thyroid cell differentiation through the modulation of phosphotyrosine activity. J Biol Chem 271:6129-6136
8. Taylor JE, Moreau J-P, Baptiste L, Moody TW 1990 Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells. Peptides 12:839-843
9. Kluxen FW, Bruns C, Lubbert H 1992 Expression cloning of a rat brain somatostatin receptor cDNA. Proc Natl Acad Sci USA 89:4618-4622
10. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S 1992 Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 89:251-255
11. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PP, O'Carroll AM, Patel YC, Schonbrunn A, Taylor JE 1995 Classification and nomenclature of somatostatin receptors. Trends Pharmacol 16:86-88
12. Kaupman K 1993 Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett 331:53-59
13. Schonbrun D, Tashjian AB 1978 Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J Biol Chem 253:6473-6483
14. Chen L, Fitzpatrick VD, Vandlen RL, Tashjian AHJ 1997 Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells. J Biol Chem 272:18666-18672
15. Rens-Domiano S, Reisine T 1992 Biochemical and functional properties of somatostatin receptors. J Neurochem 58:1987-1996
16. Liebow C, Lee MT, Kamer AR, Schally AV 1991 Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation. Proc Natl Acad Sci USA 88:2244-2248
17. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ 1994 Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis. Circulation 89:1511-1517
18. Tsuzaki S, Moses AC 1990 Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cells. Endocrinology 126:3131-3138
19. Buscail L, Delesque N, Estéve J-P, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N, Susini C 1994 Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 91:2315-2319
20. Hierowski MT, Liebow C, du Sapin K, Schally AV 1985 Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cells line. FEBS Lett 179:252-256
21. Lee MT, Liebow C, Kamer AR, Schally AV 1991 Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA 88:1656-1660
22. Pan MG, Florio T, Stork PJS 1992 G protein activation of a hormone-stimulated protein-tyrosine phosphatase in human tumor cells. Science 256:1215-1217
23. Lamberts SWJ, Krenning EP, Reubi JC 1991 The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12:450-482
24. Hershberger RE, Newman BL, Florio T, Bunzow J, Civelli O, Li X-J, Forte M, Stork PJS 1994 The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in CHO cells via pertussis toxin sensitive pathways. Endocrinology 134:1277-1285
25. Florio T, Scorziello A, Thellung S, Salzano S, Berlingieri MT, Fusco A, Schettini G 1997 Oncogene transformation of PC C13 clonal thyroid cell line that induces an autonomous pattern of proliferation that correlates with loss of basal and stimulated phosphotyrosine phosphatase activity. Endocrinology 138:3756-3763
26. Reardon DR, Dent P, Wood SL, Kong T, Sturgill TW 1997 Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from ras-transformed NIH3T3 cells: Coexpression with catalytically inactive SHP-2 blocks responsiveness. Mol Endocrinol 11:1062-1069
27. Srikant CB, Shen SH 1996 Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells. Endocrinology 137:3461-3468
28. Dhanasekaran N, Heasley LE, Johnson GL 1995 G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocr Rev 16:259-270
29. Schlessinger J, Ullrich A 1992 Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391
30. Ullrich A, Schlessinger J 1990 Signal transduction by receptors with tyrosine kinase activity. Cell 60:203-212
31. Gu YZ, Brown PJ, Loose-Mitchell DS, Stork PJS, Schonbrunn A 1995 Development and use of a receptor antibody to characterize the interaction between somatostatin receptor subtype 1 and G proteins. Mol Pharmacol 48:1004-1014
32. Cheung NW, Boyages SC 1995 Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block. Endocrinology 136:4174-4181
33. Cowley S, Paterson H, Kemp P, Marshall CJ 1994 Activation of MAP kinase kinase is necessary and sufficient for PC 12 differentiation and for transformation of NIH3T3 cells. Cell 77:841-852
34. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR 1995 A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689
35. Cattaneo MG, Amoroso D, Gussoni G, Sanguini AM, Vicentini LM 1996 A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines. FEBS Lett 397:164-168
36. Tentler JJ, Hadcock JR, Guetierrez-Hartmann A 1997 Somatostatin act by inhibiting the cyclic 3′,5′-adenosine monophosphate (cAMP)/protein kinase A pathway, cAMP response element-binding protein (CREB) phosphorylation and CREB transcriptional potency. Mol Endocrinol 11:859-866
37. Xiong Y, Hannon GJ, Zhang H, Kobayashi R, Beach D 1993 p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
38. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M 1997 Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17:5598-5611
39. Sewing A, Wiseman B, Lloyd AC, Land H 1997 High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 17:5588-5597
40. Bruder JT, Heidecker G, Rapp UR 1992 Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev 6:545-556
41. Vossler M, Yao H, York R, Rim C, Pan M-G, Stork PJS 1997 cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73-82
42. Zheng C-F, Guan K-L 1993 Dephosphorylation and inactivation of the mitogen-activated protein kinase by a mitogen-induced Thr/Tyr protein phosphatase. J Biol Chem 268:16116-16119
43. Stacy DW, Feig LA, Gibbs JB 1991 Dominant inhibitory ras mutants selectively inhibit the activity of either cellular or oncogenic ras. Mol Cell Biol 11:4053-4064
44. ras. Proc Natl Acad Sci USA 91:12706-12710
45. Imamoto A, Soriano P 1993 Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73:1117-1124
46. Avruch J, Zhang X-F, Kyriakis JM 1994 Raf meets Ras: Completing the framework of a signal transduction pathway. Trends Biochem Sci 19:279-283
47. Morrison DK, Cutler Jr RE 1997 The complexity of Raf-1 regulation. Curr Opin Cell Biol 9:174-179
48. Marais R, Light Y, Paterson HF, Marshall CJ 1995 Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J 14:3136-3145
49. Neel B 1993 Structure and function of SH2-domain containing tyrosine phosphatase. Semin Cell Biol 4:419-432
50. Rivard N, McKenzie FR, Brondello J-M, Pouysségur J 1995 The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors. J Biol Chem 270:11017-11024
51. Lorenz U, Ravichandran KS, Burakoff SJ, Neel BG 1996 Lack of SHPT1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc Natl Acad Sci USA 93:9624-9629
52. Somani A-K, Bignon JS, Mills GB, Siminovitch KA, Branch DR 1997 Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J Biol Chem 272:21113-21119
53. Wright JH, Drueckes P, Bartoe J, Zhao Z, Shen SH, Krebs EG 1997 A role for the SHP-2 tyrosine phosphatase in nerve growth-induced PC12 cell differentiation. Mol Biol Cell 8:1575-1585
54. Marais R, Wynne J, Treisman R 1993 The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393
55. Misra-Press A, Rim CS, Yao H, Roberson MS, Stork PJS 1995 A novel mitogen-activated protein kinase phosphatase: Structure, expression and regulation. J Biol Chem 270:14587-14596
56. Roberson MS, Misra-Press A, Laurance ME, Stork PJS, Maurer RA 1995 A role for mitogen activated protein kinase in mediating the ability of gonadotropin-releasing hormone to activate the glycoprotein hormone α-subunit promoter. Mol Cell Biol 15:3531-3539
57. Hazlerigg DG, Thompson M, Hastings MH, Morgan PJ 1996 Regulation of mitogen-activated protein kinase in the pars tuberalis of the ovine pituitary: Interactions between melatonin, insulin-like growth factor-1, and forskolin. Endocrinology 137:210-218
58. Conrad KE, Oberwetter JM, Vaillancourt R, Johnson GL, Gutierrez-Hartmann A 1994 Identification of the functional components of the ras signaling pathway regulating pituitary cell-specific gene expression. Mol Cell Biol 14:1553-1565
59. Yan G-Z, Ziff EB 1997 Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J Neurosci 17:6122-6132
60. Waf1/Cip1. Nature 394:295-299
61. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell KK, Luttrell LM, Lefkowitz RJ 1997 Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. J Biol Chem 272:19125-19132
62. Inglese J, Koch WJ, Touhara K, Lefkowitz RJ 1995 βγ interactions with PH domains and Ras-MAPK signaling pathways. Trends Biochem Sci 20:151-156
63. Lopez-Llasaca M, Crespo P, Pellicci PG, Gutkind JS, Wetzker R 1997 Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase γ. Science 275:394-397
64. Cohen NA, Sha Q, Makhina EN, Lopatin AN, Linder ME, Snyder SH, Nichols CG 1996 Inhibition of an inward rectifier potassium channel (Kir2.3) by G-protein beta gamma subunits. J Biol Chem 271:32301-32305
65. Sakanaka C, Ferby I, Waga I, Bito H, Shimizu T 1994 On the mechanism of cytosolic phosholipase A2 activation in CHO cells carrying somatostatin receptor: Wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem Biophys Res Commun 205:18-23
66. Garnovskaya MN, van Biesen T, Hawe B, Casanas Ramos S, Lefkowitz RJ, Raymond JR 1996 Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5-HT1A receptor via a G protein beta gamma-subunit-initiated pathway. Biochemistry 35:13716-13722
67. Crespo P, Xu N, Simonds WF, Gutkind JS 1994 Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 369:418-420
68. Ptasznik A, Traynor-Kaplan A, Bokoch GM 1995 G protein-coupled chemoattractant receptors regulate lyn tyrosine kinase-shc adapter protein signaling complexes. J Biol Chem 270:19969-19973
69. βγ-mediated MAP kinase activation by a common signalling pathway. Nature 376:781-784
70. Hawes BE, Luttrell LM, van Biesen T, Lefkowitz RJ 1996 Phosphatidylinositol 3-kinase is an early intermediate in the Gβγ-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem 271:12133-12136
71. Duckworth BC, Cantley LC 1997 Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. J Biol Chem 272:27665-27670
72. Dent P, Jelinek T, Morrison DK, Weber MJ, Sturgill TW 1995 Reversal of Raf-1 activation by purified and membrane-associated protein phosphatases. Science 268:1902-1906
73. Lopez F, Esteve J-P, Buscail L, Delesque N, Saint-Laurent N, Theveniau M, Nahmias C, Vaysse N, Susini C 1997 The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem 272:24448-24454
74. Reardon DB, Wood SL, Brautigan DL, Bell GI, Dent P, Sturgill TW 1996 Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin. Biochem J 314:401-404
75. Zeggari J, Exteve J-P, Rauly I, Cambillau C, Mazarguil H, Dufresne M, Pradayrol L, Chayvialle J-A, Vaysse N, Susini C 1994 Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Biochem J 303:441-448
76. Matthews RJ, Bowne DB, Flores E, Thomas ML 1992 Characterization of hematopoietic intracellular protein tyrosine phosphatases: Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 12:2396-2405
77. αi/o. J Biol Chem 271:3119-3123
78. Diaz B, Barnard D, Filson A, Macdonal S, King A, Marshall M 1997 Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol Cell Biol 17:4509-4516
79. Jelinek T, Dent P, Sturgill TW, Weber MJ 1996 Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol Cell Biol 16:1027-1034
80. Milarski KL, Saltiel AR 1994 Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem 269:21239-21243
81. Xiao S, Rose DW, Sasaoka T, Maegawa H, Burke Jr TR 1994 Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem 269:21244-21248
82. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K 1995 Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008-2011
83. Saxton TM, Henkemeyer M, Gasco S, Shen R, Rossi DJ, Shalaby F, Feng G-S, Pawson T 1997 Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J 19:2352-2364
84. Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG 1994 Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras. Proc Natl Acad Sci USA 91:7335-7339
85. Hadari YR, Douhara H, Lax I, Schlessinger J 1998 Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol Cell Biol 18:3966-3973
86. Peng Z-Y, Cartwright CA 1995 Regulation of Src tyrosine kinase and Syp tyrosine phosphatase by their cellular association. Oncogene 11:1955-1962
87. c-src in cells infected with avian erythroblastosis virus. Proc Natl Acad Sci USA 84:5793-5797
88. c-src by overexpression of a protein tyrosine phosphatase. Nature 359:336-339
89. Tsui HW, Simovitch KA, deSouza L, Tsui FWL 1993 Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 4:124-129
90. Vaillancourt RR, Gardner AM, Johnson GL 1994 B-Raf dependent regulation of the MEK-1/MAP kinase pathway in PC12 cells and regulation by cAMP. Mol Cell Biol 14:6522-6530